Cargando…
Overexpression of primary microRNA 221/222 in acute myeloid leukemia
BACKGROUND: Acute myeloid leukemia (AML) is a hematopoietic malignancy with a dismal outcome in the majority of cases. A detailed understanding of the genetic alterations and gene expression changes that contribute to its pathogenesis is important to improve prognostication, disease monitoring, and...
Autores principales: | Rommer, Anna, Steinleitner, Katarina, Hackl, Hubert, Schneckenleithner, Christine, Engelmann, Maria, Scheideler, Marcel, Vlatkovic, Irena, Kralovics, Robert, Cerny-Reiterer, Sabine, Valent, Peter, Sill, Heinz, Wieser, Rotraud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3733744/ https://www.ncbi.nlm.nih.gov/pubmed/23895238 http://dx.doi.org/10.1186/1471-2407-13-364 |
Ejemplares similares
-
A gene expression profile associated with relapse of cytogenetically normal acute myeloid leukemia is enriched for leukemia stem cell genes
por: Hackl, Hubert, et al.
Publicado: (2015) -
Tetracycline Regulator Expression Alters the Transcriptional Program of Mammalian Cells
por: Hackl, Hubert, et al.
Publicado: (2010) -
Molecular and genetic alterations associated with therapy resistance and relapse of acute myeloid leukemia
por: Hackl, Hubert, et al.
Publicado: (2017) -
EVI1 Inhibits Apoptosis Induced by Antileukemic Drugs via Upregulation of CDKN1A/p21/WAF in Human Myeloid Cells
por: Rommer, Anna, et al.
Publicado: (2013) -
EVI1 promotes tumor growth via transcriptional repression of MS4A3
por: Heller, Gerwin, et al.
Publicado: (2015)